UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

Current Report Pursuant Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): ~~January~~April 3021, 2015

Trimedyne, Inc.

(Exact Name of Registrant as

Specified in its Charter)

Nevada		36-3094439
(State of Other Jurisdiction of Incorporation or Organization)		(IRS Employer Identification No.)

5 Holland, #223, Irvine CA 92618
(Address of Principal Executive Offices)

Registrant's Telephone Number, Including Area Code: (949) 951-3800

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ~~(see General Instructions A.2. below)~~:

~~[ ]~~o Written communications pursuant to Rule 425 under the Securities Act o Soliciting material pursuant to Rule 14a-12 under the Exchange Act o Pre-commencement communications pursuant to Rule 14d-2(17b) ~~CFR~~under ~~230.425~~the Exchange Act o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Section 5 — Corporate Governance and Management

Item 5.02.(b) ~~Departure of Directors or Certain Officers;~~ Election of Directors~~; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.~~

On ~~January 30~~April 21, 2015, ~~Marvin~~the P.Board ~~Loeb,~~of ~~Sc.D,~~Directors ~~notified~~ of Trimedyne, Inc,. (the “Company”), ofby ~~his~~written ~~decision to resign from offices of CEO and Chairman and the Board of Directors of the Company~~consent, ~~effective~~elected ~~immediately~~Edward D. ~~This~~Spriegel ~~resignation~~as ~~was not~~ a ~~result~~Director of ~~any disagreement with~~ the Company~~, its management or the Company’s Board or any matter relating to the Company’s operations, policies or practices~~. In addition, DrMr. ~~Loeb~~ Spriegel was ~~elected~~appointed toChairman of the ~~office~~Audit ofand ~~Chief~~Compensation ~~Scientific~~Committees ~~Officer~~ of the Company, ~~without~~relieving ~~diminishing~~Donald ~~his~~Baker ~~current~~of ~~cash~~his ~~compensation~~duties thereunder.

~~Further,~~Edward ~~Glenn~~ D. ~~Yeik~~Spriegel, ~~current~~age ~~President~~77, ~~COO~~currently is the Corporate Secretary and a Director of the ~~Company~~ARCOA Group, an end-of-use assets services company, founded in 1990. In addition, he is also the President of CIMCA, an insurance marketing and consulting services company, which he founded in 1965. Previously, he was ~~elected~~Vice President of Marketing for American Mid-States Life Insurance, Assistant to the ~~additional~~President ~~office~~and ofAgency ~~Chairman~~Secretary for Mayflower Life Insurance Company, ~~effective~~held ~~immediately~~supervisory and isaccounting ~~the~~positions ~~acting~~for ~~Principal~~Life ~~Executive~~and ~~Officer~~AH Premium, Zurich-American Life Insurance Companies and Investors Security Group of Life Company and held various middle management positions at Sun Life Insurance Company of Canada.

~~Further, one additional director was appointed to the Company’s Board of Directors on January 30, 2015, effective immediately:~~2

~~Alan E. Loeb, age 50, is the sole Trustee of the four Trusts established by Dr. Loeb, which together constitute the Company’s principal stockholder.~~SIGNATURES

~~There~~Pursuant ~~are~~to nothe ~~arrangements~~requirements orof ~~understandings~~the ~~between~~Securities ~~any~~Exchange ~~director and~~Act ~~any~~of ~~other~~1934, this ~~person~~report ~~pursuant~~has tobeen ~~which~~signed ~~such~~below ~~director~~by ~~was~~the ~~selected~~following aspersons aon ~~director,~~behalf ~~other~~of ~~than~~ the ~~provisions~~registrant ofand in the ~~Transaction~~capacities ~~Agreement relating~~and toon the ~~appointment~~dates ~~of directors~~indicated.

	Trimedyne, Inc.

Date: April 27, 2015	By	/s/ Glenn D. Yeik
		Glenn D. Yeik
		Principal Executive Officer


Date: April 27, 2015	By	/s/ Jeffrey S. Rudner
		Jeffrey S. Rudner
		Chief Accounting Officer

~~SIGNATURES~~3

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

	Trimedyne, Inc.
Date: February 4, 2015	By	/s/ Glenn D. Yeik
		Glenn D. Yeik
		Principal Executive Officer
Date: February 4, 2015	By	/s/ Jeffrey S. Rudner
		Jeffrey S. Rudner
		Chief Accounting Officer

Filing Compare · TRIMEDYNE INC